Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › New York › NPI 1437230034
Hospital

NYU Langone Hospitals

NYU Langone Hospitals was paid $117.59M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is J2350, Injection, ocrelizumab, 1 mg — 33% of everything it billed.

33Billing provider infoNYU LANGONE HOSPITALS
NEW YORK, NY 10016
33aNPI1437230034assigned 10/18/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$117.59M
24GClaims691,088
24DCodes billed228
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in New York

Rank by total paid#3 of 33
Median peer was paid$171K
This provider vs. median689×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,080$217K
201940,713$6.45M
2020101,613$15.28M
2021129,954$20.52M
2022142,072$25.30M
2023150,156$29.47M
2024incomplete120,500$20.36M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J2350 Injection, ocrelizumab, 1 mg 33% 1,467 1,322 $39.25M
J9271 Injection, pembrolizumab, 1 mg 18% 2,331 1,827 $21.49M
J2323 Injection, natalizumab, 1 mg 6.1% 1,224 1,174 $7.14M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.8% 20,568 13,657 $3.35M
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 2.3% 713 447 $2.74M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.2% 16,945 14,182 $2.56M
J9312 Injection, rituximab, 10 mg 2.1% 430 306 $2.51M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2.0% 1,662 976 $2.36M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 26,764 10,470 $2.15M
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 1.8% 302 200 $2.10M
96415 1.4% 6,663 5,186 $1.69M
77386 1.4% 4,977 694 $1.68M
216 more codes
J0897 Injection, denosumab, 1 mg 1.4% 966 $1.62M
78815 Positron emission tomography (PET) for limited area imaging 1.3% 1,582 $1.58M
77412 1.2% 4,111 $1.44M
J2505 Injection, pegfilgrastim, 6 mg 1.1% 495 $1.32M
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 722 $1.17M
77336 <1% 3,678 $1.13M
J0485 Injection, belatacept, 1 mg <1% 1,450 $1.02M
J1439 Injection, ferric carboxymaltose, 1 mg <1% 1,369 $909K
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg <1% 355 $855K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,979 $784K
80053 Comprehensive metabolic panel <1% 56,713 $777K
J9299 Injection, nivolumab, 1 mg <1% 177 $773K
77067 Screening mammography, bilateral, including computer-aided detection <1% 7,042 $595K
96375 Therapeutic injection; each additional sequential IV push <1% 20,882 $579K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 2,847 $567K
96361 Intravenous infusion, hydration; each additional hour <1% 4,421 $538K
J0185 Injection, aprepitant, 1 mg <1% 3,014 $535K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 28,549 $480K
76641 <1% 6,477 $456K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 450 $452K
J1756 Injection, iron sucrose, 1 mg <1% 9,405 $442K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg <1% 292 $440K
J3380 Injection, vedolizumab, intravenous, 1 mg <1% 90 $419K
J9035 Injection, bevacizumab, 10 mg <1% 114 $414K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 217 $400K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,582 $380K
96416 <1% 1,703 $363K
36430 <1% 2,388 $336K
31575 <1% 864 $335K
77300 <1% 1,187 $307K
36415 Collection of venous blood by venipuncture <1% 51,616 $289K
96417 <1% 4,570 $281K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,561 $277K
77334 <1% 1,196 $260K
J9070 Cyclophosphamide, 100 mg <1% 600 $236K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 59,459 $230K
77066 Tomosynthesis, mammo <1% 2,338 $228K
J2469 Injection, palonosetron hcl, 25 mcg <1% 6,365 $221K
99213 Doctor's office visit, returning patient (routine) <1% 2,850 $205K
96409 <1% 1,949 $192K
10005 <1% 487 $190K
83615 <1% 15,224 $170K
77063 Screening digital breast tomosynthesis, bilateral <1% 7,011 $160K
77301 <1% 237 $156K
77065 Tomosynthesis, mammo <1% 2,018 $156K
88185 <1% 707 $153K
96367 <1% 2,904 $144K
96411 <1% 2,225 $140K
96401 <1% 1,715 $137K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 13,630 $129K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,791 $122K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,749 $114K
76642 <1% 2,192 $114K
86850 <1% 5,074 $110K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,106 $106K
77290 <1% 272 $106K
93017 <1% 1,807 $105K
96402 <1% 2,175 $99K
J7030 Infusion, normal saline solution , 1000 cc <1% 47,657 $80K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 197 $71K
J9264 Injection, paclitaxel protein-bound particles, 1 mg <1% 40 $71K
J0640 Injection, leucovorin calcium, per 50 mg <1% 1,320 $71K
36591 <1% 1,783 $67K
77062 <1% 2,127 $65K
77338 <1% 322 $64K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 944 $63K
86901 <1% 5,089 $58K
J9267 Injection, paclitaxel, 1 mg <1% 2,098 $56K
77280 <1% 162 $54K
82728 <1% 5,301 $52K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 729 $48K
86945 <1% 1,818 $44K
86900 <1% 5,093 $43K
96523 <1% 1,007 $42K
86480 <1% 783 $41K
77061 <1% 1,271 $40K
82378 <1% 3,072 $39K
J9045 Injection, carboplatin, 50 mg <1% 1,749 $39K
70551 Magnetic resonance imaging, brain; without contrast material <1% 281 $37K
77080 <1% 1,271 $36K
J3490 Unclassified drugs <1% 2,486 $35K
87497 <1% 1,339 $35K
J9202 Goserelin acetate implant, per 3.6 mg <1% 59 $34K
84703 <1% 8,451 $32K
77332 <1% 194 $32K
82784 <1% 2,016 $31K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,933 $31K
83883 <1% 1,748 $27K
J7050 Infusion, normal saline solution, 250 cc <1% 14,156 $26K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 413 $26K
86923 <1% 1,390 $26K
71250 <1% 1,906 $24K
84443 Thyroid stimulating hormone (TSH) <1% 3,405 $24K
83735 <1% 5,651 $23K
87799 <1% 426 $22K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,103 $21K
J9190 Injection, fluorouracil, 500 mg <1% 1,739 $21K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 162 $21K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 66 $19K
77049 <1% 63 $19K
J9263 Injection, oxaliplatin, 0.5 mg <1% 608 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 1,753 $17K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 659 $17K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 9,640 $17K
88184 <1% 450 $17K
82607 <1% 1,608 $16K
84439 <1% 2,188 $16K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 79 $15K
86334 <1% 1,147 $15K
96377 <1% 633 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,514 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 774 $14K
86304 <1% 995 $14K
99195 <1% 140 $14K
88172 <1% 360 $14K
82746 <1% 1,566 $14K
J9370 Vincristine sulfate, 1 mg <1% 1,373 $13K
96368 <1% 860 $13K
84100 <1% 3,794 $12K
86300 <1% 819 $12K
85730 <1% 2,364 $11K
J9206 Injection, irinotecan, 20 mg <1% 326 $11K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 115 $11K
86301 <1% 767 $10K
83540 <1% 2,563 $10K
85045 <1% 3,940 $10K
88173 <1% 374 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,259 $10K
85610 <1% 2,602 $10K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 5,835 $9K
83550 <1% 2,359 $9K
84165 <1% 1,453 $8K
S0028 Injection, famotidine, 20 mg <1% 5,217 $8K
81003 <1% 4,368 $8K
86769 <1% 327 $8K
80061 Lipid panel <1% 610 $8K
86140 <1% 2,279 $8K
84153 <1% 667 $7K
86803 <1% 869 $7K
86706 <1% 919 $7K
J9000 Injection, doxorubicin hydrochloride, 10 mg <1% 444 $7K
77295 <1% 36 $7K
86704 <1% 833 $6K
85652 <1% 3,304 $6K
80076 <1% 600 $6K
90686 <1% 433 $6K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 367 $5K
82948 <1% 1,633 $5K
J2785 Injection, regadenoson, 0.1 mg <1% 155 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 274 $5K
86790 <1% 281 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,857 $5K
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg <1% 144 $4K
87340 <1% 752 $4K
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 1,819 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 241 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 317 $3K
G0008 Administration of influenza virus vaccine <1% 230 $3K
83021 <1% 200 $3K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 47 $3K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 25 $3K
J9060 Injection, cisplatin, powder or solution, 10 mg <1% 158 $3K
99201 <1% 70 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 838 $3K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 122 $3K
C1889 Implantable/insertable device, not otherwise classified <1% 86 $2K
85670 <1% 550 $2K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 3,325 $2K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 246 $2K
82550 <1% 437 $2K
36416 <1% 121 $2K
85379 <1% 281 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 413 $2K
85240 <1% 121 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 12 $2K
80050 General health panel <1% 89 $1K
83010 <1% 135 $1K
A4648 Tissue marker, implantable, any type, each <1% 92 $1K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 79 $1K
86160 <1% 83 $1K
84702 <1% 91 $1K
84156 <1% 384 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,081 $1K
84481 <1% 110 $975.02
84550 <1% 295 $963.19
85246 <1% 35 $929.57
82105 <1% 122 $886.22
80197 <1% 147 $874.38
82248 <1% 239 $811.98
88342 <1% 14 $781.74
90656 <1% 44 $721.21
71046 Radiologic examination, chest; 2 views <1% 28 $690.19
C8937 Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) <1% 31 $650.88
84480 <1% 51 $434.16
85384 <1% 64 $346.54
90662 <1% 15 $337.16
84466 <1% 30 $315.07
J8540 Dexamethasone, oral, 0.25 mg <1% 55 $309.12
84403 <1% 13 $296.82
87086 Culture, bacterial; quantitative colony count, urine <1% 59 $278.87
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 226 $213.39
J0461 Injection, atropine sulfate, 0.01 mg <1% 105 $210.08
85613 <1% 26 $193.10
85732 <1% 38 $161.52
85027 <1% 62 $156.28
81001 <1% 79 $147.29
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 40 $143.28
83690 <1% 33 $141.55
85303 <1% 12 $107.75
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 26 $91.90
85300 <1% 12 $77.78
J3480 Injection, potassium chloride, per 2 meq <1% 80 $67.90
J3475 Injection, magnesium sulfate, per 500 mg <1% 26 $65.36
82150 <1% 16 $63.61
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 139 $50.62
77417 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMITH, WESLEY (VP REVENUE CYCLE)
Parent organizationNYU LANGONE HOSPITALS
Same official

Other billing entities under SMITH, WESLEY

Full network →
ProviderLocationPaid
NYU Langone HospitalsBrooklyn, NY$303.18M
NYU Langone HospitalsNew York, NY$238.69M
NYU Langone HospitalsMineola, NY$69.77M
NYU Langone HospitalsNew York, NY$32.22M
NYU Langone HospitalsNew York, NY$3.50M
NYU Langone HospitalsBrooklyn, NY$453K
NYU Langone HospitalsBrooklyn, NY$99K
NYU Langone HospitalsBrooklyn, NY$9K
NYU Hospitals CenterNew York, NY$55.44

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.